Works matching IS 03407004 AND DT 2014 AND VI 63 AND IP 8

Results: 9

Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 8, p. 847, doi. 10.1007/s00262-014-1561-8

By:

Kosaka, Akemi;
Ohkuri, Takayuki;
Okada, Hideho

Publication type:

Article

Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 8, p. 797, doi. 10.1007/s00262-014-1554-7

By:

Kobayashi, Masanori;
Shimodaira, Shigetaka;
Nagai, Kazuhiro;
Ogasawara, Masahiro;
Takahashi, Hidenori;
Abe, Hirofumi;
Tanii, Mitsugu;
Okamoto, Masato;
Tsujitani, Sun-ichi;
Yusa, Seiichi;
Ishidao, Takefumi;
Kishimoto, Junji;
Shibamoto, Yuta;
Nagaya, Masaki;
Yonemitsu, Yoshikazu

Publication type:

Article

Altered chemokine production and accumulation of regulatory T cells in intestinal adenomas of APC mice.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 8, p. 807, doi. 10.1007/s00262-014-1555-6

By:

Akeus, Paulina;
Langenes, Veronica;
Mentzer, Astrid;
Yrlid, Ulf;
Sjöling, Åsa;
Saksena, Pushpa;
Raghavan, Sukanya;
Quiding-Järbrink, Marianne

Publication type:

Article

Interleukin-2-stimulated natural killer cells are less susceptible to mycophenolate mofetil than non-activated NK cells: possible consequences for immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 8, p. 821, doi. 10.1007/s00262-014-1556-5

By:

Brehm, Claudia;
Huenecke, Sabine;
Esser, Ruth;
Kloess, Stephan;
Quaiser, Andrea;
Betz, Sibille;
Zimmermann, Olga;
Soerensen, Jan;
Passweg, Jakob;
Klingebiel, Thomas;
Schwabe, Dirk;
Bader, Peter;
Koehl, Ulrike

Publication type:

Article

Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 8, p. 835, doi. 10.1007/s00262-014-1557-4

By:

Park, Jungsun;
Li, Haiyan;
Zhang, Mingjun;
Lu, Yong;
Hong, Bangxing;
Zheng, Yuhuan;
He, Jin;
Yang, Jing;
Qian, Jianfei;
Yi, Qing

Publication type:

Article

Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 8, p. 779, doi. 10.1007/s00262-014-1551-x

By:

Hu, Yinin;
Petroni, Gina;
Olson, Walter;
Czarkowski, Andrea;
Smolkin, Mark;
Grosh, William;
Chianese-Bullock, Kimberly;
Slingluff, Craig

Publication type:

Article

B7-H1 signaling is integrated during CD8 T cell priming and restrains effector differentiation.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 8, p. 859, doi. 10.1007/s00262-014-1563-6

By:

Gibbons, Rachel;
Liu, Xin;
Harrington, Susan;
Krco, Christopher;
Kwon, Eugene;
Dong, Haidong

Publication type:

Article

Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 8, p. 757, doi. 10.1007/s00262-014-1578-z

By:

Bruserud, Øystein;
Tvedt, Tor;
Paulsen, Petter;
Ahmed, Aymen;
Gedde-Dahl, Tobias;
Tjønnfjord, Geir;
Slåstad, Heidi;
Heldal, Dag;
Reikvam, Håkon

Publication type:

Article

Antitumor activity and safety of combination therapy with the Toll-like receptor 9 agonist IMO-2055, erlotinib, and bevacizumab in advanced or metastatic non-small cell lung cancer patients who have progressed following chemotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 8, p. 787, doi. 10.1007/s00262-014-1547-6

By:

Smith, David;
Conkling, Paul;
Richards, Donald;
Nemunaitis, John;
Boyd, Thomas;
Mita, Alain;
Bourdonnaye, Guillaume;
Wages, David;
Bexon, Alice

Publication type:

Article